David E. Wheadon is Director of Vaxart, Inc.. Currently has a direct ownership of 30,750 shares of VXRT, which is worth approximately $19,065. The most recent transaction as insider was on Jun 11, 2024, when has been sold 16,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.8K
0% 3M change
108.47% 12M change
Total Value Held $19,065

David E. Wheadon Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 11 2024
BUY
Grant, award, or other acquisition
-
16,000 Added 34.22%
30,750 Common Stock
Jun 26 2023
BUY
Grant, award, or other acquisition
-
7,375 Added 33.33%
14,750 Common Stock
Aug 04 2022
BUY
Grant, award, or other acquisition
-
7,375 Added 50.0%
7,375 Common Stock

Also insider at

KRTX
Karuna Therapeutics, Inc. Healthcare
SHC
Sotera Health Co Healthcare
CCXI
ChemoCentryx, Inc.
DEW

David E. Wheadon

Director
South San Francisco, CA

Track Institutional and Insider Activities on VXRT

Follow Vaxart, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VXRT shares.

Notify only if

Insider Trading

Get notified when an Vaxart, Inc. insider buys or sells VXRT shares.

Notify only if

News

Receive news related to Vaxart, Inc.

Track Activities on VXRT